Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

May 7, 2017

Chicago, IL
Hyatt Regency Chicago
Regency Ballroom A & B

Navigating the Inflammatory Bowel Disease Pipeline: The Horizon is Bright


May 7, 2017
6:15 pm – 8:15 pm
Hyatt Regency Chicago
Regency Ballroom A & B
Chicago, Illinois

Outcomes for patients with IBD have been steadily enhanced over the past decade due to the evolution of therapeutic and management strategies that target pathologic abnormalities. As standard of care and novel strategies for the management of these diseases are further investigated and refined, it is essential that healthcare professionals who care for these patients are provided with guidance for the successful integration of these potentially paradigm-changing advances into clinical practice.

The Navigating the Inflammatory Bowel Disease Pipeline: The Horizon is Bright symposium is designed to provide partipants with an enhanced ability to evaluate and successfully integrate optimal therapeutic and management strategies into everyday clinical practice for the advancement of clinical outcomes in these patient populations.


Faculty

Bruce E. Sands, MD, MS
Icahn School of Medicine at Mount Sinai
New York, New York

Stephen B. Hanauer, MD
Northwestern Feinberg School of Medicine
Chicago, Illinois

Corey A. Siegel, MD, MS
Dartmouth-Hitchcock Medical Center
Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire

 

Scientific Agenda

Sunday, May 7, 2017

6:15 PM

Registration and dinner

6:45 PM

Welcome, pre-activity learner survey via audience response system (ARS)
Bruce E. Sands, MD, MS

6:50 PM

Mechanisms of Disease: Small Molecule Pipeline for IBD
Bruce E. Sands, MD, MS

7:10 PM

Mechanisms of Disease: Biologic Pipeline for IBD
Stephen B. Hanauer, MD

7:30 PM

The Era of Personalized IBD Management: The Future is Bright
Corey A. Siegel, MD, MS

7:50 PM

Interactive Panel Discussion: Future Challenges and Opportunities to Advance Patient Outcomes in IBD
Moderator: Bruce E. Sands, MD, MS

8:05 PM

Closing remarks, recap of key messages, and post-activity learner survey via ARS
Bruce E. Sands, MD, MS

8:15 PM

Adjourn

 

Continuing Education

Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

Imedex, LLC designates this live educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)

Successful completion of this CME activity enables a participant to earn up to 1.5 MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Who Should Attend

Gastroenterologists, internists, gastroenterology nurses, and other healthcare professionals (physicians-in-training, nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD will also benefit from the education.

Objectives

After successful completion of this activity, participants will be able to:

      • Relate key pathophysiologic processes to current and emerging treatment approaches for IBD
      • Analyze data from clinical trials investigating biologics and immunomodulatory agents for patients with IBD

 

Registration

Registration is Complimentary!

Registration for this CME activity is limited to clinicians in practice. For all other professionals, we will be taking stand-by seating onsite based upon seating availability.

Available seating will be based on room capacity. Seating is limited and pre-registration does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating for clinicians will be first-come first-serve until capacity is met. All other professionals standing by will be seated upon availability.

Clinicians and stand-by professionals must have their DDW badge for entrance.

How To Register: You may register online at www.imedex.com or by calling Imedex at +1 (800) 233 0957 (international callers please call +1 (678) 242 0906).  For assistance, please contact registration@imedex.com. Registration confirmations will be issued before the meeting.

Registration Inclusions: Registration includes admittance to all scientific sessions, activity materials, processing of certificates of participation or continuing education credit, and all event functions as specified in the agenda.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

 

Support

Supported in part by an educational grant from Pfizer

 

Organizer

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
FacebookTwitterLinkedInEmail

For registration inquiries:
Tel.: +1 (800) 233 0957
Direct: +1 (678) 242 0906
Fax: +1 (678) 242-0870
Email: registration@imedex.com